Abstract

The use of induction chemotherapy (CT) is controversial. We compared the survival of head and neck cancer patients receiving docetaxel-or platinum-based induction CT before concomitant chemoradiotherapy (CCRT) with the survival of those receiving upfront CCRT alone. Data fromtheNationalHealth Insurance and cancer registry databases in Taiwan were linked and analyzed. We enrolled patients who had head and neck cancer between January 1, 2002andDecember 31, 2011. Followup was from the index date to December 31, 2013.We included head and neck patients diagnosed according to the International Classification of Diseases, Ninth Revision, Clinical Modification codes 140.0-148.9 who were aged
Original languageEnglish
Pages (from-to)e2845
JournalMedicine (United States)
Volume95
Issue number7
DOIs
Publication statusPublished - 2016

    Fingerprint

Cite this